• About
    • About
    • Management
    • Board of Directors
    • Scientific Advisors
  • Pipeline
    • Pipeline
    • ART27.13 – Cannabinoid Agonist
    • ART26.12 – FABP5 Inhibitor
    • ART12.11 – CBD Cocrystal
  • Investors
    • Investors
    • Overview
    • News & Events
    • Company Info
    • Presentations
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Email Alerts
  • Media
  • Contact

Artelo Biosciences

Artelo Biosciences

  • About
    • Management
    • Board of Directors
    • Scientific Advisors
  • Pipeline
    • ART27.13 – Cannabinoid Agonist
    • ART26.12 – FABP5 Inhibitor
    • ART12.11 – CBD Cocrystal
    • Publications
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Presentations
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Email Alerts
  • Media
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • Media
    • IR Calendar
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Presentations
  • Financial Info
    • Overview
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Email Alerts
  • News & Events

  • Overview
  • Press Releases
  • Media
  • IR Calendar

Artelo Biosciences to Present at the H.C. Wainwright Global Investment Conference on May 24th

May 16, 2022 8:55am EDT

Artelo Biosciences to Present at MicroCap Rodeo’s Spring into Action Best Ideas Virtual Conference on May 16th

May 13, 2022 8:30am EDT

Artelo Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update

May 12, 2022 8:30am EDT

Artelo Biosciences to Present at Investor Summit Group's Q2 In-Person Conference in New York

Apr 25, 2022 7:30am EDT

Artelo Biosciences Reports Positive Pre-clinical Results for Lead Program in Cancer-Related Cachexia

Apr 13, 2022 8:30am EDT

Artelo Expands Collaboration with Trinity College Dublin to Investigate Cellular Biology of Fatty Acid Binding Protein (FABP) Inhibition In Cancer

Mar 28, 2022 9:25am EDT

Artelo Biosciences to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th

Mar 22, 2022 9:00am EDT

Artelo Biosciences Reports Four-Month 2021 Financial Results in Connection with its Amended Fiscal Year End and Provides Business Update

Mar 21, 2022 8:30am EDT

Artelo Biosciences Receives Notice of Allowance for Method-of-Use Patent in the United States for ART12.11, a Proprietary Cocrystal of Cannabidiol

Mar 02, 2022 8:30am EST

Artelo Biosciences Reports First Quarter Fiscal Year 2022 Financial Results and Provides Business Update

Jan 12, 2022 8:30am EST
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
Next
  • Email Alerts
  • Contacts
  • RSS News Feed
© Copyright 2022 - Artelo Biosciences, Inc.     info@artelobio.com    |     Terms of Use    |     Privacy Policy    |     Cookies Policy
^